Major bleeding
3 papers2 findings
- Human trial1
- Humans2
Associations
2Klemera-Doubal biological age
upin humans1HR 2.12
1 study
Klemera-Doubal biological age
upin humans1HR 2.12
Klemera-Doubal biological age predicts major bleeding in humans (Adjusted HR 2.12 (95% CI 1.60–2.83)).
“composite outcomes, death, major bleeding, SSE, and heart failure were 2.11 (1.82-2.45), 2.53 (2.06-3.11), 2.12 (1.60-2.83), 1.96 (1.37-2.78), and 1.83 (1.42-2.38), respectively”
HumansPatients with atrial fibrillation; quartile 4 KDM biological age; adjusted analysisMedian 35.9 monthsBoth; 1424 (41.8%) femalesn = 3,405
Journal of thrombosis and thrombolysis12 Jan 2026
History of falls
upin humans1
1 study
History of falls
upin humans1
History of falls are associated with major bleeding in humans.
“had a higher risk of major adverse events, including all-cause mortality, thromboembolism, and major bleeding.”
Humanspatients with atrial fibrillationn = 20,875
GeroScience28 Aug 2025
Latest
17 in 12 monthsCJC Open
Frailty and Bleeding Events in Heart Failure: Insights from the JROADHF-NEXT
Cohort study of 2,940 peopleHeart failure
Journal of the American Heart Association
Artificial Intelligence-Derived Electrocardiographic Age Enhances Stroke Risk Stratification in Patients With Atrial Fibrillation With a CHA₂DS₂-VA Score of 1
Cohort study of 832 peopleAtrial fibrillation
Alzheimer's & Dementia
Platelet count polygenic scores may modify the effect of aspirin in primary prevention of dementia
Randomised trial in 13,541 peopleAspirin
European Heart Journal
Half-dose rivaroxaban vs antiplatelet therapy for preventing silent cerebral embolism after left atrial appendage occlusion: the HALO-SCE trial
Randomised trial in 164 peopleInterventions
JACC CardioOncology
Hemoglobin Decline After Oral Anticoagulation Initiation and Subsequent Cancer Detection in Patients With Atrial Fibrillation
Cohort study of 6,789 peopleHemoglobin
Clinical Pharmacology and Therapeutics
Triglyceride Polygenic Score Identifies Individuals Who May Respond Differently to Aspirin in Primary Prevention
Randomised trial in 13,571 peopleAspirin
Journal of Clinical Medicine
Aspirin in Primary Prevention of CVD: A Pragmatic Outline and Advice for Treatment Personalization
ReviewAspirin
European Heart Journal
Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer's disease: a Swedish nationwide study
Cohort study of 7,308 peopleAtrial fibrillation
Trends in Cardiovascular Medicine
Smartwatch and wearable detection of atrial fibrillation: Current evidence and clinical implications
ReviewAtrial fibrillation
Journal of Thrombosis and Thrombolysis
Impact of biological age versus chronological age on clinical outcomes in patients with atrial fibrillation: insights from the COOL-AF registry
Cohort study of 3,405 peopleAtrial fibrillation